Outcomes and costs of implementing a community-based intervention for hypertension in an urban slum in Kenya

Samuel Oji Oti, Steven van de Vijver, Gabriela B Gomez, Charles Agyemang, Thaddaeus Egondi, Catherine Kyobutungi, Karien Stronks, Samuel Oji Oti, Steven van de Vijver, Gabriela B Gomez, Charles Agyemang, Thaddaeus Egondi, Catherine Kyobutungi, Karien Stronks

Abstract

Objective: To describe the processes, outcomes and costs of implementing a multi-component, community-based intervention for hypertension among adults aged > 35 years in a large slum in Nairobi, Kenya.

Methods: The intervention in 2012-2013 was based on four components: awareness-raising; improved access to screening; standardized clinical management of hypertension; and long-term retention in care. Using multiple sources of data, including administrative records and surveys, we described the inputs and outputs of each intervention activity and estimated the outcomes of each component and the impact of the intervention. We also estimated the costs associated with implementation, using a top-down costing approach.

Findings: The intervention reached 60% of the target population (4049/6780 people), at a cost of 17 United States dollars (US$) per person screened and provided access to treatment for 68% (660/976) of people referred, at a cost of US$ 123 per person with hypertension who attended the clinic. Of the 660 people who attended the clinic, 27% (178) were retained in care, at a cost of US$ 194 per person retained; and of those patients, 33% (58/178) achieved blood pressure control. The total intervention cost per patient with blood pressure controlled was US$ 3205.

Conclusion: With moderate implementation costs, it was possible to achieve hypertension awareness and treatment levels comparable to those in high-income settings. However, retention in care and blood pressure control were challenges in this slum setting. For patients, the costs and lack of time or forgetfulness were barriers to retention in care.

Figures

Fig. 1
Fig. 1
Outcome and impact indicators for each stage in the cascade of hypertension diagnosis and management in the community-based intervention in Kenya, 2012–2013

References

    1. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
    1. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
    1. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001. November 27;104(22):2746–53. 10.1161/hc4601.099487
    1. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007. December 15;370(9604):2054–62. 10.1016/S0140-6736(07)61699-7
    1. van de Vijver SJ, Oti SO, Agyemang C, Gomez GB, Kyobutungi C. Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya. J Hypertens. 2013. May;31(5):1018–24. 10.1097/HJH.0b013e32835e3a56
    1. Joshi MD, Ayah R, Njau EK, Wanjiru R, Kayima JK, Njeru EK, et al. Prevalence of hypertension and associated cardiovascular risk factors in an urban slum in Nairobi, Kenya: a population-based survey. BMC Public Health. 2014;14(1):1177. 10.1186/1471-2458-14-1177
    1. Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens. 2006. January;20(1):67–71. 10.1038/sj.jhh.1001923
    1. Bovet P, Gervasoni J-P, Mkamba M, Balampama M, Lengeler C, Paccaud F. Low utilization of health care services following screening for hypertension in Dar es Salaam (Tanzania): a prospective population-based study. BMC Public Health. 2008;8(1):407. 10.1186/1471-2458-8-407
    1. Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, Martin-Peprah R, et al. Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension. 2004 May. May;43(5):1017–22. 10.1161/01.HYP.0000126176.03319.d8
    1. Chaturvedi S, Pant M, Yadav G; Neelam. Hypertension in Delhi: prevalence, awareness, treatment and control. Trop Doct. 2007 July. July;37(3):142–5. 10.1258/004947507781524593
    1. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in Mozambique: urban/rural gap during epidemiological transition. Hypertension. 2009. July;54(1):77–83. 10.1161/HYPERTENSIONAHA.109.132423
    1. Zachariah MG, Thankappan KR, Alex SC, Sarma PS, Vasan RS. Prevalence, correlates, awareness, treatment, and control of hypertension in a middle-aged urban population in Kerala. Indian Heart J. 2003. May-Jun;55(3):245–51.
    1. Oti SO, van de Vijver SJ, Kyobutungi C, Gomez GB, Agyemang C, Moll van Charante EP, et al. A community-based intervention for primary prevention of cardiovascular diseases in the slums of Nairobi: the SCALE UP study protocol for a prospective quasi-experimental community-based trial. Trials. 2013;14(1):409. 10.1186/1745-6215-14-409
    1. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I follow-up study cohort. Lancet. 2008. March 15;371(9616):923–31. 10.1016/S0140-6736(08)60418-3
    1. van de Vijver S, Oti S, Tervaert TC, Hankins C, Kyobutungi C, Gomez GB, et al. Introducing a model of cardiovascular prevention in Nairobi’s slums by integrating a public health and private-sector approach: the SCALE-UP study. Glob Health Action. 2013;6:22510. 10.3402/gha.v6i0.22510
    1. Beguy D, Elung'ata P, Mberu B, Oduor C, Wamukoya M, Nganyi B, et al. Health and demographic surveillance system profile: The Nairobi urban health and demographic surveillance system (NUHDSS). Int J Epidemiol. 2015. April; 44(2)):462-71..
    1. Emina J, Beguy D, Zulu EM, Ezeh AC, Muindi K, Elung’ata P, et al. Monitoring of health and demographic outcomes in poor urban settlements: evidence from the Nairobi urban health and demographic surveillance system. J Urban Health. 2011. June;88(S2) Suppl 2:S200–18. 10.1007/s11524-011-9594-1
    1. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003. November;21(11):1983–92. 10.1097/00004872-200311000-00002
    1. van de Vijver S, Oti SO, Gomez GB, Agyemang C, Egondi T, van Charante EM, et al. Impact evaluation of a community-based intervention for prevention of cardiovascular diseases in the slums of Nairobi: the SCALE-UP study. Glob Health Action. 2016. March 24;9(0):30922. 10.3402/gha.v9.30922
    1. Smith WC, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves. BMJ. 1990. April 14;300(6730):981–3. 10.1136/bmj.300.6730.981
    1. Ikeda N, Sapienza D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad AH, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014. January 1;92(1):10–19C. 10.2471/BLT.13.121954
    1. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013. September 4;310(9):959–68. 10.1001/jama.2013.184182
    1. Zulu EM, Beguy D, Ezeh AC, Bocquier P, Madise NJ, Cleland J, et al. Overview of migration, poverty and health dynamics in Nairobi city’s slum settlements. J Urban Health. 2011. June;88(S2) Suppl 2:S185–99. 10.1007/s11524-011-9595-0
    1. Kimani JK, Ettarh R, Kyobutungi C, Mberu B, Muindi K. Determinants for participation in a public health insurance program among residents of urban slums in Nairobi, Kenya: results from a cross-sectional survey. BMC Health Serv Res. 2012;12(1):66. 10.1186/1472-6963-12-66
    1. Kimani-Murage EW, Schofield L, Wekesah F, Mohamed S, Mberu B, Ettarh R, et al. Vulnerability to food insecurity in urban slums: experiences from Nairobi, Kenya. J Urban Health. 2014. December;91(6):1098–113. 10.1007/s11524-014-9894-3
    1. van Mourik MS, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010;10(1):25. 10.1186/1471-2261-10-25
    1. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization; 2013.
    1. Gopalappa C, Stover J, Shaffer N, Mahy M. The costs and benefits of option B+ for the prevention of mother-to-child transmission of HIV. AIDS. 2014. January;28 Suppl 1:S5–14. 10.1097/QAD.0000000000000083
    1. Brouwer ED, Watkins D, Olson Z, Goett J, Nugent R, Levin C. Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review. BMC Public Health. 2015;15(1):1183. 10.1186/s12889-015-2538-z
    1. Data – Kenya [Internet]. Washington: World Bank; 2014. Available from: [cited 2016 Apr 22].
    1. Laurence YV, Griffiths UK, Vassall A. Costs to health services and the patient of treating tuberculosis: a systematic literature review. Pharmacoeconomics. 2015. September;33(9):939–55. 10.1007/s40273-015-0279-6
    1. Galárraga O, Wirtz VJ, Figueroa-Lara A, Santa-Ana-Tellez Y, Coulibaly I, Viisainen K, et al. Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics. 2011. July;29(7):579–99.
    1. Urban world: ten years into the millennium. Nairobi: United Nations Human Settlements Programme; 2010.
    1. Gaziano TA, Abrahams-Gessel S, Denman CA, Montano CM, Khanam M, Puoane T, et al. An assessment of community health workers’ ability to screen for cardiovascular disease risk with a simple, non-invasive risk assessment instrument in Bangladesh, Guatemala, Mexico, and South Africa: an observational study. Lancet Glob Health. 2015. September;3(9):e556–63. 10.1016/S2214-109X(15)00143-6

Source: PubMed

3
Sottoscrivi